Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in "cold" and I-O refractory metastatic solid tumors Meeting Abstract
| Authors: | Wilky, B.; El-Khoueiry, A.; Bullock, A.; Tsimberidou, A.; Mahadevan, D.; Margolin, K.; Trent, J.; Bockorny, B.; Moser, J.; Hosein, P.; Fakih, M.; Schlecter, B.; Thomas, J.; Balmanoukian, A.; Sanborn, R.; Abou-Alfa, G.; Schwartz, G.; Hanna, D.; Feliu, W. O.; Grossman, J.; Rosenthal, K.; Godwin, J.; Patel, J.; Bullock, B.; Stebbing, J.; Rawal, B.; Cole, H.; Delepine, C.; Chow, J.; Walker, R.; MacDermaid, C.; Chand, D.; Gordon, M.; Lenz, H. J.; O'Day, S. |
| Abstract Title: | Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in "cold" and I-O refractory metastatic solid tumors |
| Meeting Title: | 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 10 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2022-11-01 |
| Start Page: | A810 |
| Language: | English |
| ACCESSION: | WOS:000919423400734 |
| DOI: | 10.1136/jitc-2022-SITC2022.0778 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 778 -- Source: Wos |
